LLY
HealthcareEli Lilly and Company
$984.11+6.86 (+0.70%)
Prev Close
$977.25
Open
$980.13
High
$1003.22
Low
$978.00
Volume
1.38M
Market Cap
$921.90B
P/E
42.88
Div Yield
0.01%
Over the past 12 months, insider activity at Eli Lilly and Company (LLY) has been dominated by selling, with 6 insider purchases totaling $3.40M and 20 insider sales totaling $361.99M. The most recent insider transaction was by Brown Adrienne S (EVP, President LLY Imm), who sold $176.8K worth of shares on Feb 18, 2026. Eli Lilly and Company operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $921.90B.
Buys (12M)
6
$3.40M
Sells (12M)
20
$361.99M
Net Activity
Net Seller
$358.58M
Active Insiders
21
last 12 mo
LLY Price Chart
LLY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Brown Adrienne S | EVP, President LLY Imm | Sell | 170 | $1039.79 | $176.8K | 0 |
| Feb 16, 2026↗ | Custer Kenneth L. | EVP & President, Card Met Hlth | Sell | 91 | $1043.55 | $95.0K | 0 |
| Feb 16, 2026↗ | Montarce Lucas | EVP & CFO | Sell | 160 | $1038.26 | $166.1K | 0 |
| Feb 16, 2026↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 82 | $1034.33 | $84.8K | 0 |
| Feb 3, 2026↗ | Dozier Eric | EVP, Chief People Officer | Sell | 1,273 | $1037.14 | $1.32M | 0 |
| Feb 3, 2026↗ | Hakim Anat | EVP, GC & Secretary | Sell | 2,953 | $1037.29 | $3.06M | 0 |
| Feb 3, 2026↗ | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,591 | $1037.44 | $1.65M | 0 |
| Feb 3, 2026↗ | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 1,752 | $1037.19 | $1.82M | 0 |
| Feb 3, 2026↗ | Rau Diogo | EVP & CIDO | Sell | 1,674 | $1036.86 | $1.74M | 0 |
| Feb 3, 2026↗ | Ricks David A | President, Chair, and CEO | Sell | 14,297 | $1037.13 | $14.83M | 0 |
| Feb 3, 2026↗ | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Sell | 5,641 | $1037.20 | $5.85M | 0 |
| Feb 3, 2026↗ | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Sell | 1,909 | $1037.35 | $1.98M | 0 |
| Feb 3, 2026↗ | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,512 | $1037.40 | $1.57M | 0 |
| Jan 8, 2026↗ | LILLY ENDOWMENT INC | 10 percent owner | Sell | 292,148 | $1103.49 | $322.38M | 92,188,200 |
| Jan 6, 2026↗ | LILLY ENDOWMENT INC | 10 percent owner | Sell | 1,390 | $1085.01 | $1.51M | 92,189,100 |
| Nov 13, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $1010.50 | $1.01M | 0 |
| Aug 15, 2025↗ | Montarce Lucas | EVP & CFO | Buy | 715 | $691.79 | $494.6K | 0 |
| Aug 14, 2025↗ | Alvarez Ralph | Director | Buy | 758 | $660.25 | $500.5K | 0 |
| Aug 13, 2025↗ | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Buy | 1,000 | $647.36 | $647.4K | 0 |
| Aug 12, 2025↗ | Ricks David A | President, Chair, and CEO | Buy | 1,632 | $644.77 | $1.05M | 0 |
| Aug 12, 2025↗ | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Buy | 1,000 | $634.41 | $634.4K | 0 |
| Aug 12, 2025↗ | Sulzberger Gabrielle | Director | Buy | 117 | $641.18 | $75.0K | 0 |
| Aug 12, 2025↗ | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,250 | $627.01 | $783.8K | 0 |
| Aug 4, 2025↗ | Seymour Melissa | EVP, Global Quality | Sell | 427 | $739.93 | $316.0K | 0 |
| May 27, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $716.41 | $716.4K | 0 |
| May 15, 2025↗ | Yuffa Ilya | EVP & President, LLY Int'l | Sell | 1,250 | $749.24 | $936.5K | 0 |
| Mar 13, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $818.24 | $818.2K | 0 |
| Mar 3, 2025↗ | Dozier Eric | EVP, Chief People Officer | Sell | 1,066 | $920.81 | $981.6K | 0 |
| Feb 4, 2025↗ | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,282 | $810.82 | $1.04M | 0 |
| Feb 4, 2025↗ | Rau Diogo | EVP & CIDO | Sell | 1,466 | $811.24 | $1.19M | 0 |
| Feb 4, 2025↗ | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Sell | 4,004 | $811.01 | $3.25M | 0 |
| Feb 4, 2025↗ | White Anne E. | EVP & Pres, Lilly Neuroscience | Sell | 1,457 | $811.14 | $1.18M | 0 |
LLY Insider Buying Activity
The following table shows recent insider purchases of Eli Lilly and Company (LLY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025↗ | Montarce Lucas | EVP & CFO | Buy | 715 | $691.79 | $494.6K | 0 |
| Aug 14, 2025↗ | Alvarez Ralph | Director | Buy | 758 | $660.25 | $500.5K | 0 |
| Aug 13, 2025↗ | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Buy | 1,000 | $647.36 | $647.4K | 0 |
| Aug 12, 2025↗ | Ricks David A | President, Chair, and CEO | Buy | 1,632 | $644.77 | $1.05M | 0 |
| Aug 12, 2025↗ | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Buy | 1,000 | $634.41 | $634.4K | 0 |
| Aug 12, 2025↗ | Sulzberger Gabrielle | Director | Buy | 117 | $641.18 | $75.0K | 0 |
LLY Insider Selling Activity
The following table shows recent insider sales of Eli Lilly and Company (LLY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Brown Adrienne S | EVP, President LLY Imm | Sell | 170 | $1039.79 | $176.8K | 0 |
| Feb 16, 2026↗ | Custer Kenneth L. | EVP & President, Card Met Hlth | Sell | 91 | $1043.55 | $95.0K | 0 |
| Feb 16, 2026↗ | Montarce Lucas | EVP & CFO | Sell | 160 | $1038.26 | $166.1K | 0 |
| Feb 16, 2026↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 82 | $1034.33 | $84.8K | 0 |
| Feb 3, 2026↗ | Dozier Eric | EVP, Chief People Officer | Sell | 1,273 | $1037.14 | $1.32M | 0 |
| Feb 3, 2026↗ | Hakim Anat | EVP, GC & Secretary | Sell | 2,953 | $1037.29 | $3.06M | 0 |
| Feb 3, 2026↗ | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,591 | $1037.44 | $1.65M | 0 |
| Feb 3, 2026↗ | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 1,752 | $1037.19 | $1.82M | 0 |
| Feb 3, 2026↗ | Rau Diogo | EVP & CIDO | Sell | 1,674 | $1036.86 | $1.74M | 0 |
| Feb 3, 2026↗ | Ricks David A | President, Chair, and CEO | Sell | 14,297 | $1037.13 | $14.83M | 0 |
| Feb 3, 2026↗ | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Sell | 5,641 | $1037.20 | $5.85M | 0 |
| Feb 3, 2026↗ | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Sell | 1,909 | $1037.35 | $1.98M | 0 |
| Feb 3, 2026↗ | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,512 | $1037.40 | $1.57M | 0 |
| Jan 8, 2026↗ | LILLY ENDOWMENT INC | 10 percent owner | Sell | 292,148 | $1103.49 | $322.38M | 92,188,200 |
| Jan 6, 2026↗ | LILLY ENDOWMENT INC | 10 percent owner | Sell | 1,390 | $1085.01 | $1.51M | 92,189,100 |
| Nov 13, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $1010.50 | $1.01M | 0 |
| Aug 12, 2025↗ | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,250 | $627.01 | $783.8K | 0 |
| Aug 4, 2025↗ | Seymour Melissa | EVP, Global Quality | Sell | 427 | $739.93 | $316.0K | 0 |
| May 27, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $716.41 | $716.4K | 0 |
| May 15, 2025↗ | Yuffa Ilya | EVP & President, LLY Int'l | Sell | 1,250 | $749.24 | $936.5K | 0 |
| Mar 13, 2025↗ | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $818.24 | $818.2K | 0 |
| Mar 3, 2025↗ | Dozier Eric | EVP, Chief People Officer | Sell | 1,066 | $920.81 | $981.6K | 0 |
| Feb 4, 2025↗ | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,282 | $810.82 | $1.04M | 0 |
| Feb 4, 2025↗ | Rau Diogo | EVP & CIDO | Sell | 1,466 | $811.24 | $1.19M | 0 |
| Feb 4, 2025↗ | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Sell | 4,004 | $811.01 | $3.25M | 0 |
| Feb 4, 2025↗ | White Anne E. | EVP & Pres, Lilly Neuroscience | Sell | 1,457 | $811.14 | $1.18M | 0 |
LLY Insiders
Similar Stocks to LLY
JNJ
Johnson & Johnson
$241.86-0.07%
$583.29B
ABBV
AbbVie Inc.
$220.81-2.02%
$398.49B
MRK
Merck & Co., Inc.
$115.92+0.00%
$286.57B
AMGN
Amgen Inc.
$366.74-0.29%
$198.26B
GILD
Gilead Sciences, Inc.
$144.25-0.66%
$180.27B
PFE
Pfizer Inc.
$26.62-0.89%
$152.73B
BMY
Bristol-Myers Squibb Company
$58.93-0.04%
$120.05B
BIIB
Biogen Inc.
$183.58-0.71%
$27.14B